Skip to content

H2020FP7HORIZON

Janssen Pharmaceutica NV

Country
BEBelgium
Defence projects
0
Projects, all programmes
131
As coordinator
6
EU contribution (CORDIS)
EUR 10,443,749
Active
2008 to 2025

Projects

131 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
RHAPSODYAssessing risk and progression of prediabetes and type 2 diabetes to enable disease modification - Sofia ref.: 115881H20202016ParticipantEUR 0
PEARRLPharmaceutical Education And Research with Regulatory Links: Innovative drug development strategies and regulatory tools tailored to facilitate earlier access to medicinesH20202016ParticipantEUR 250,560
RADAR-CNSRemote Assessment of Disease and Relapse in Central Nervous System DisordersH20202016ParticipantEUR 0
ZIKAllianceA global alliance for Zika virus control and preventionH20202016ParticipantEUR 55,089
PRISMPsychiatric Ratings using Intermediate Stratified Markers - Sofia ref.: 115916H20202016ParticipantEUR 0
PHAGOInflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976H20202016ParticipantEUR 0
ROADMAPReal world Outcomes across the AD spectrum for better care: Multimodal data Access Platform - Sofia ref.: 116020H20202016ParticipantEUR 0
CompBioMedA Centre of Excellence in Computational BiomedicineH20202016ParticipantEUR 125,025
EPADEuropean Prevention of Alzheimer’s Dementia ConsortiumFP72015CoordinatorNot stated
IDEASImproving Design, Evaluation and Analysis of early drug development StudiesH20202015ParticipantEUR 250,560
SyDADSynaptic Dysfunction in Alzheimer DiseaseH20202015ParticipantEUR 250,560
ADAPT-SMARTAccelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890H20202015ParticipantEUR 0
ModLifeAdvancing Modelling for Process-Product Innovation, Optimization, Monitoring and Control in Life Science IndustriesH20202015PartnerEUR 0
IPIEIntelligent Assessment of Pharmaceutical in the EnvironmentFP72015ParticipantNot stated
ExCAPEExascale Compound Activity Prediction EngineH20202015Third partyNot stated
ULTRA-DDUnrestricted Leveraging of Targets for Research Advancement and Drug DiscoveryFP72015ParticipantNot stated
WEB-RADRRecognising Adverse Drug ReactionsFP72014ParticipantNot stated
PREPAREPlatform foR European Preparedness Against (Re-)emerging EpidemicsFP72014ParticipantNot stated
EBODACCommunication strategy and tools for optimizing the impact of Ebola vaccination deployment – Sofia ref.: 115847H20202014ParticipantEUR 0
EBISCEuropean Bank for induced pluripotent Stem CellsFP72014CoordinatorNot stated

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.